STRS Ohio’s Jade Biosciences JBIO Stock Holding History

STRS Ohio’s Portfolio JBIO Stock Details JBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$73.3K	Buy	+3,300	New	+$68.8K	﹤0.01%	1946
2026 Q1	–	Sell	-900	Closed	-$13.9K	–	2134
2025 Q4	$13.9K	Hold	900	–	–	﹤0.01%	2124
2025 Q3	$7.77K	Sell	900 -4,000	-82%	-$32.7K	﹤0.01%	2165
2025 Q2	$49K	Buy	4,900 +4,837	+7,678%	+$165K	﹤0.01%	2028
2025 Q1	$5.52K	Hold	63	–	–	﹤0.01%	1894
2024 Q4	$5.83K	Hold	63	–	–	﹤0.01%	1859
2024 Q3	$4.6K	Hold	63	–	–	﹤0.01%	1951
2024 Q2	$3.65K	Hold	63	–	–	﹤0.01%	1940
2024 Q1	$65K	Sell	63 -3	-5%	-$2.29K	﹤0.01%	1740
2023 Q4	$52K	Hold	66	–	–	﹤0.01%	1768
2023 Q3	$31K	Hold	66	–	–	﹤0.01%	1847
2023 Q2	$39K	Hold	66	–	–	﹤0.01%	1833
2023 Q1	$46K	Hold	66	–	–	﹤0.01%	1795
2022 Q4	$67K	Hold	66	–	–	﹤0.01%	1778
2022 Q3	$38K	Hold	66	–	–	﹤0.01%	1863
2022 Q2	$35K	Hold	66	–	–	﹤0.01%	1909
2022 Q1	$42K	Hold	66	–	–	﹤0.01%	1964
2021 Q4	$27K	Hold	66	–	–	﹤0.01%	2081
2021 Q3	$48K	Buy	+66	New	+$36.9K	﹤0.01%	2074

Other funds holding JBIO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

STRS Ohio's JBIO Position: Q2 2026 in Review

STRS Ohio opened a new position in Jade Biosciences (JBIO) in Q2 2026: 3,300 shares worth $73.3K. The stake represents ﹤0.01% of the portfolio and ranks #1946 among its holdings. This is a return to the name: STRS Ohio previously reported a position in JBIO as recently as Q4 2025.

STRS Ohio first reported a position in JBIO in Q3 2021 and has held it in 19 quarters since. 154 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

STRS Ohio held 3,300 shares of Jade Biosciences worth $73.3K as of Q2 2026.
Jade Biosciences was a new STRS Ohio position in Q2 2026.
Jade Biosciences made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #1946 holding.
STRS Ohio first reported a position in Jade Biosciences in Q3 2021 and has held it in 19 quarters since.
154 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.